John Connolly, PhD

Interim CEO

Management Team

  • 20+ years of research experience in immunotherapy and has published more than 100 papers and chapters in peer-reviewed journals. As a human immunologist, his research interests focus on immune monitoring and immunometabolism.
  • Associate professor at National University of Singapore and an adjunct associate professor of Immunology at Baylor University, where he served on the Board of Governors for the Institute of Biomedical Sciences.
  • Serves as director for the IMPACT Program, a multi-disciplinary national initiative focused building cell therapy manufacturing, clinical and regulatory capability for Singapore.
  • Founding director of the Singapore Immunology Network’s Immunomonitoring Platform
  • PhD in Immunology from Dartmouth Medical School and studied human dendritic cell biology under Dr. Michael Fanger.

Management Team

Scientific Advisory Board